AstraZeneca PLC against Johnson & Johnson — live side-by-side technical comparison.
Prices as of 2026-11-11T17:09:51+00:00 UTC · updates daily
JNJ leads 6 of the 7 windows we measure — over 1 month AZN is +16.3% and JNJ +5.3%; over year to date AZN is +0.2% and JNJ +34.2%. The AZN/JNJ price ratio stands at 0.6632, above its 50-day average of 0.63, and below the 200-day average of 0.7281. A ratio above its own average means AZN is gaining on JNJ; on this reading the recent edge belongs to AZN.
Compare AZN and JNJ: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| AZN | JNJ | |
|---|---|---|
| Price | $184.20 | $277.73 |
| 1 day | -1.4% | -1.1%lead |
| 5 days | -2.5% | +0.5%lead |
| 1 month | +16.3%lead | +5.3% |
| 6 months | +1.3% | +25.4%lead |
| Year to date | +0.2% | +34.2%lead |
| 1 year | +3.4% | +43.3%lead |
| 2 years | +42.2% | +79.1%lead |
| 52-week position | 52% of range | 94% of range |
| 52-week range | $153.41–$212.71 | $193.07–$283.25 |
| vs 50-day average | above $167.93 | above $266.50 |
| vs 200-day average | above $180.19 | above $249.20 |
| RSI (14) | 62 | 58 |
| Market cap | — | $675.9B |
| Analyst target | — | $279.41 (-0.5%) |
| Analysts | — | 22 |
| Consensus | — | Buy |
| Next earnings | Oct 30, 2026 | Jan 26, 2027 |
AZN trades at $184.20, above its 50-day average of $167.93, and above the 200-day at $180.19. It sits at 52% of its 52-week range ($153.41–$212.71); 14-day RSI is 62, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $187.12 (1.6% away) and the first support below is $183.01 (0.7% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
JNJ trades at $277.73, above its 50-day average of $266.50, and above the 200-day at $249.20. It sits at 94% of its 52-week range ($193.07–$283.25); 14-day RSI is 58, in neutral territory; an average session moves it about 2.6%. For levels, the first level overhead is $281.54 (1.4% away) and the first support below is $275.53 (0.8% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
Both move about the same amount day to day (2.7% and 2.6% of price), so the same position size carries comparable risk in either.
The comparison turns on those levels: AZN clearing $187.12 or losing $183.01; JNJ clearing $281.54 or losing $275.53. Until one of them gives way, the relative reading above stands.